210 related articles for article (PubMed ID: 21153520)
21. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
22. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide.
Roumenina LT; Popov KT; Bureeva SV; Kojouharova M; Gadjeva M; Rabheru S; Thakrar R; Kaplun A; Kishore U
Biochim Biophys Acta; 2008 Sep; 1784(9):1271-6. PubMed ID: 18513495
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
24. Blood platelets activate the classical pathway of human complement.
Peerschke EI; Yin W; Grigg SE; Ghebrehiwet B
J Thromb Haemost; 2006 Sep; 4(9):2035-42. PubMed ID: 16961611
[TBL] [Abstract][Full Text] [Related]
25. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
Sjöberg AP; Manderson GA; Mörgelin M; Day AJ; Heinegård D; Blom AM
Mol Immunol; 2009 Feb; 46(5):830-9. PubMed ID: 18962898
[TBL] [Abstract][Full Text] [Related]
26. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.
Pondman KM; Pednekar L; Paudyal B; Tsolaki AG; Kouser L; Khan HA; Shamji MH; Ten Haken B; Stenbeck G; Sim RB; Kishore U
Nanomedicine; 2015 Nov; 11(8):2109-18. PubMed ID: 26169151
[TBL] [Abstract][Full Text] [Related]
27. An amphioxus gC1q protein binds human IgG and initiates the classical pathway: Implications for a C1q-mediated complement system in the basal chordate.
Gao Z; Li M; Ma J; Zhang S
Eur J Immunol; 2014 Dec; 44(12):3680-95. PubMed ID: 25174509
[TBL] [Abstract][Full Text] [Related]
28. Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.
Odorczuk M; Keil LB; DeBari VA
Inflamm Res; 1999 Oct; 48(10):524-6. PubMed ID: 10563468
[TBL] [Abstract][Full Text] [Related]
29. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
30. Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System.
Laursen NS; Pedersen DV; Gytz H; Zarantonello A; Bernth Jensen JM; Hansen AG; Thiel S; Andersen GR
Front Immunol; 2020; 11():1504. PubMed ID: 32849513
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
32. Headless C1q: a new molecular tool to decipher its collagen-like functions.
Fouët G; Bally I; Signor L; Häußermann K; Thielens NM; Rossi V; Gaboriaud C
FEBS J; 2021 Mar; 288(6):2030-2041. PubMed ID: 32869492
[TBL] [Abstract][Full Text] [Related]
33. Regulation of the alternative pathway of human complement by C1q.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
[TBL] [Abstract][Full Text] [Related]
34. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
35. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.
Gaboriaud C; Juanhuix J; Gruez A; Lacroix M; Darnault C; Pignol D; Verger D; Fontecilla-Camps JC; Arlaud GJ
J Biol Chem; 2003 Nov; 278(47):46974-82. PubMed ID: 12960167
[TBL] [Abstract][Full Text] [Related]
36. Liposome-induced activation of the classical complement pathway does not require immunoglobulin.
Marjan J; Xie Z; Devine DV
Biochim Biophys Acta; 1994 Jun; 1192(1):35-44. PubMed ID: 8204648
[TBL] [Abstract][Full Text] [Related]
37. RHP is antigenically related to factor H and binds to the globular heads of C1q.
Easterbrook-Smith SB; Wilson MR; Wines BD
Mol Immunol; 1992 Oct; 29(10):1203-7. PubMed ID: 1388244
[TBL] [Abstract][Full Text] [Related]
38. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
39. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells.
Martin M; Leffler J; Blom AM
J Biol Chem; 2012 Sep; 287(40):33733-44. PubMed ID: 22879587
[TBL] [Abstract][Full Text] [Related]
40. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.
Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB
J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
